Organizer & Producer
Day 2 – April 6 2016
| 08:00-09:30 |
Registration | |||||||
| 09:30-10:10 |
|
|||||||
| 10:10-10:40 |  Coffee Break and Poster Session |
|||||||
| 10:40 -12:20 | Hall A | Hall B | Hall C | Hall D | ||||
| Stem cells in Tissue Engineering | Pluripotent Stem Cells in Disease | Regulation, Quality and Clinical Development | Stem Cell Applications in Metabolic Diseases | |||||
| Chair: Smadar Cohen | Chair: Nissim Benvenisty | Chair: Sigalit Ariely-Portnoy | Chair: Yuval Dor | |||||
| 10:40 -11:00 | Stem Cells in Tissue Engineering Smadar Cohen Ben-Gurion University, Israel  |
Haploid Human Embryonic Stem Cells Nissim Benvenisty The Hebrew University, Israel |
Cell Therapy Submissions in Europe: Successes and Failures Marcos Timon AEMPS, Spain  |
Cell Therapy for Diabetes: Human Embryonic Stem-Cells Derived Functional Insulin Producing Cells Kfir Molakandon Kadimastem Ltd., Israel |
||||
| 11:00 -11:20 | Regulation of Cardiomyocyte Differentiation and Dedifferentiation Induced by Varying Matrix Rigidity Benny Geiger Weizmann Institute of Science, Israel |
The Origin, Fate & Regulation of Stem Cells of the Corneal Epithelium: Lessons from iPS Cells and Lineage Tracing Ruby Shalom Technion, Israel |
Cell Therapy Products: Israeli MOH - Regulatory Update Ofra Axelrod MOH, Israel |
Beta-Cell Replication: the Role of the Pancreatic Microenvironment Limor Landman Tel Aviv University, Israel |
||||
| 11:20 -11:40 | The Matrix Reloaded: Engineering Functioning Tissue using Nature’s Building Blocks Marcelle Machluf Technion, Israel |
Using Patient-Specific Fibroblasts and iPSC-Derived Cardiomyocytes to Probe Monogenic Heart Diseases Rivka Ofir Ben Gurion University of the Negev, Israel |
Conclusions from Case studies: 10 Points to Consider when Developing a Cell Therapy Product Diana Gershtein GSAP, Israel |
Industrialization of a Cell Based Autologous Therapy Targeting Diabetes: Industrialization of Liver Cell Amplification Process from Culture Dish to Xpansion™ Multi-Plate Bioreactor Sara Ferber Orgenesis, Israel |
||||
| 11:40 -12:00 | Microgel Suspension Culture System for hMSCs Bioprocessing Dror Seliktar Technion, Israel |
Differential Methylation of the GGGGCC Repeat Expansion between C9/ALS HESCs and Patient-Derived iPS Cells Rachel Eiges The Hebrew University of Jerusalem, Israel |
The “Yellow Brick Road” to Methods Validation for Human Cell Therapy Products Ruth Goldberg Pluristem, Israel |
Development of an Endocrine Micro-Pancreas Eduardo Mitrani The Hebrew University of Jerusalem, Israel |
||||
| 12:00 -12:20 | Cardiac Tissue Engineering: from Development of Engineered Autologous Tissues to the Fabrication of Bionic Hearts Sharon Fleischer Tel Aviv University, Israel |
Latent Infection and Reactivation of the Human-Specific Pathogenic Virus Varicella Zoster using hESC-Derived Neurons- an in-Vitro Model for Herpes Zoster (Shingles) Ron Goldstein Bar-Ilan University, Israel |
Risk Based Thinking in Shipping Logistics Ilana Avhar World Courier, Israel |
The βAir Immune Barrier, A Potent Machinery for Protecting Xenogeneic Islets and Stem-Cell Based β-cells from Host Immune Systemβ-cells from Host Immune System Uriel Barkai ßeta-O2 Technologies Ltd. Israel |
||||
| 12:30 -13:30 |  Lunch break |
|||||||
| Hall A | Hall B | Hall C | Hall D | |||||
| Programming of Adult Tissues | Epigenetics of Stem Cells | Combination Products: Cells, Genes and Devices In collaboration with  |
Biology and Translation of Cell Technologies | |||||
| 13:30 -15:10 |
Chair: Sara Ferber | Chair: Yehudit Bergman | Chair: Yael Porat, Ohad Karnieli |
Chair: Yaron Fuchs | ||||
| 13:30 -13:50 | Generating Insulin Producing Cells by Transcription Factor-Induced Lliver Cell Transdifferentiation Sara Ferber Orgenesis / Sheba Medical Center, Israel |
Epigenetic Programming of Stem Cell Fate Decisions Yehudit Bergman The Hebrew University of Jerusalem, Israel |
Bringing Cell Therapies to Every Clinic - Vision and Practical Means Yael Porat (10min) BioGenCell Ltd, Israel Devises as a Tool to Standardize Cell and Gene Therapy - New Means to Make Cell Therapy Widely Available Ohad Karnieli (10 min) Karnieli Ltd, Israel Next Generation Cell Therapy Manufacturing Eytan Abraham (15 min) Lonza, USA  Engineering of Vascularized Flap Using Human Adipose Derived Endothelial Cells and Mesenchymal Stem Cells Yulia Shandalov (15 min) Technion, Israel Laser Stimulated Stem Cells in the Bone Marrow has Beneficial Effect on the Ischemic Heart and Kidney–a Bench to Bedside Study Uri Oron (15 min) Tel Aviv University, Israel Challenges in Developing Serum-Free Xeno-Free Differentiation Media for hMSC from Various Sources Toward Cell Therapy Mira Genser-Nir (15 min) Biological Industries, Israel Israeli Activity in the International ISO TC276 Standards for Biotechnology Sagi Nahum (15 min) Pluristem, Israel |
SEPT4/ARTS Regulates Stem Cell Apoptosis and Skin Regenration Yaron Fuchs Technion, Israel |
||||
| 13:50 -14:10 | Stem Cells are Key Players in Novel Skeletal Therapies Dan Gazit The Hebrew University of Jerusalem, Israel |
Epitranscriptomics - the Roles of mRNA Modification in Early Embryonic Cell Fate Decisions Sharon Moshkovitz Sheba Medical Center, Israel |
Metabolic Shifts in the Developing Tissue: A Potential Non-Genetic Means for Regulation of Cell Specification Arieh Moussaieff The Hebrew University of Jerusalem, Israel |
|||||
| 14:10 -14:30 | Programming the Adult Human Kidney Benny Dekel Sheba Medical Center, Israel |
Chromatin Plasticity in Early Embryonic Stem Cell Differentiation: Imaging and in Silico Approaches Eran Meshorer The Hebrew University of Jerusalem, Israel |
Higher Genomic Stability of Mesenchymal Stem Cells Cultured for Regenerative Purposes: Lessons From the Tissue Specific Nature of Cells Isolated from Different Adult Sources Nir Shani Tel Aviv Sourasky Medical Center, Israel |
|||||
| 14:30 -14:50 | The Fragile Identity of Pancreatic Beta Cells Yuval Dor The Hebrew University of Jerusalem, Israel |
Epigenetic Predisposition to Reprogramming Fates Iftach Nachman Tel Aviv University, Israel |
Computer-Based Assessment of Embryo Quality for Infertility Clinical Applications Amnon Buxboim The Hebrew University of Jerusalem, Israel |
|||||
| 14:50 -15:10 | MicroRNAs Regulate Beta Cell Identity and Function Eran Hornstein Weizmann Institute of Science, Israel |
Large Scale Analysis of Loss of Imprinting in Human Pluripotent Stem Cells Shiran Bar Hebrew University, Jerusalem, Israel |
Mechanism of Action Placental-Derived Cellular Therapy for the Treatment of Peripheral Artery Disease Racheli Ofir Pluristem, Israel |
|||||
| 15:10 -15:40 | Coffee Break |
|||||||
| 15:40 -16:20 |
|
|||||||
| 16:20 -16:30 |  Announcement of Winning Posters Closing Remarks |
|||||||
 |
 |
 |